Meridian Bioscience Reports Third Fiscal Quarter 2017 Operating Results, Including Non-Cash Goodwill Impairment Charge,Declares Regular Cash Dividend, and Reaffirms Fiscal 2017 Guidance Excluding the
Go back to Meridian Bioscience Reports Third Fiscal Quarter 2017 Operating Results, Including Non-Cash Goodwill Impairment Charge,Declares Regular Cash Dividend, and Reaffirms Fiscal 2017 Guidance Excluding the| Meridian Bioscience, Inc. (NASDAQ: VIVO) | Delayed: 5.87 +0.42 (7.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.45 | 52 Week High | $21.49 | |||
| Open | $5.51 | 52 Week Low | $15.75 | |||
| Day High | $6.24 | P/E | 6.67 | |||
| Day Low | $5.35 | EPS | $0.88 | |||
| Volume | 1,863,790 | |||||
